Research & Innovation
Advancing cancer care through clinical research
Oklahoma Cancer Specialists and Research Institute integrates clinical research directly into patient care, providing access to advanced therapies and clinical trials that help shape the future of oncology.
Research integrated with care
OCSRI is committed to advancing cancer treatment through participation in clinical trials and research studies. Our physicians and research teams work closely to ensure that eligible patients have access to innovative therapies while receiving high-quality, personalized care.
As a research-focused oncology practice, OCSRI participates in national research networks and collaborates with leading organizations to bring cutting-edge treatments to patients in our community.
Clinical Trials
Explore active research studies
Clinical trials evaluate new approaches to cancer treatment and care. Eligibility varies by diagnosis and treatment history.
Phase 2
NRG GU012 (SAMURAI)
Randomized Phase II Stereotactic Ablative Radiation Therapy (SABR) for Metastatic Unresected Renal Cell Carcinoma Receiving Immunotherapy
View detailsNone
EAA173
Daratumumab to Enhance Therapeutic Effectiveness of Revlimid in Smoldering Myeloma (DETER-SMM)
View detailsPhase 3
R3767-ONC-22122
A Phase 3 Study Of Fixed Dose Combinations Of Fianlimab And Cemiplimab Versus Relatlimab And Nivolumab In Participants With Unresectable Or Metastatic
View detailsInterested in participating in research?
Clinical trials may be an option depending on diagnosis, treatment history, and eligibility criteria. Our research team can help determine if a study is right for you.
Contact the Research Team